Verge Genomics Will Use Modality.AI in Its ALS Phase 1b Clinical Trial...
LYME DISEASE | American Speech-Language-Hearing Association (ASHA) Convention 2023
Speech Biomarkers of Lyme Disease: A First Exploratory Analysis
J. Liscombe, H. Kothare, M. Neumann, V. Ramanarayanan
🏆 This poster was awarded the “Meritorious Poster” and honored as part of ASHA’s “Changemaker" Session.